Diabetes in pregnancy: Timing and mode of delivery

Current Diabetes Reports

Volumn 14, Issue 7, 2014, Pages

  Maso, Gianpaolo ^a   Piccoli, Monica ^a   Parolin, Sara ^a   Restaino, Stefano ^a   Alberico, Salvatore ^a  

^a INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

Author keywords

Birth injuries; Cesarean delivery; Delivery; Excessive fetal growth; Gestational diabetes; Induction of labor; Labor; Macrosomia; Obesity; Pregestational diabetes; Pregnancy; Review; Shoulder dystocia; Type 1 diabetes; Type 2 diabetes

Indexed keywords

INSULIN;

ARTICLE; BIRTH INJURY; BIRTH WEIGHT; BRACHIAL PLEXUS INJURY; CESAREAN SECTION; CLINICAL EVALUATION; DELIVERY; DIABETIC ANGIOPATHY; DIET THERAPY; EVIDENCE BASED PRACTICE; FETUS DEATH; FETUS ECHOGRAPHY; FETUS HYPOXIA; GESTATIONAL AGE; GLUCOSE INTOLERANCE; GLYCEMIC CONTROL; HIGH RISK PREGNANCY; HUMAN; HYPERTENSION; INSULIN TREATMENT; LABOR; LABOR MANAGEMENT; MACROSOMIA; META ANALYSIS (TOPIC); NEWBORN DISEASE; NEWBORN INTENSIVE CARE; OBESITY; OBSTETRICIAN; PERINATAL MORBIDITY; PERINATAL MORTALITY; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PREMATURE LABOR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SHOULDER DYSTOCIA; STILLBIRTH; SYSTEMATIC REVIEW (TOPIC); THIRD TRIMESTER PREGNANCY; UTERINE CERVIX RIPENING; VAGINAL DELIVERY; DIABETES MELLITUS; FEMALE; PREGNANCY; PREGNANCY COMPLICATION;

DELIVERY, OBSTETRIC; DIABETES MELLITUS; DIABETES, GESTATIONAL; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84901548817     PISSN: 15344827     EISSN: 15390829     Source Type: Journal    
DOI: 10.1007/s11892-014-0506-0     Document Type: Article

References (102)

1. Bellamy L, Casas JP, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773-9.
2. Hayfaa A, Wahabi HA, Esmaeil SA, Fayed A, et al. Pre-existing diabetes mellitus and adverse pregnancy outcomes. BMC Res Notes. 2012;5:496.
3. Persson M, Norman M, Hanson U. Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study. Diabetes Care. 2009;32:2005-9.
4. Knight KM, Pressman EK, Hackney DN, et al. Perinatal outcomes in type 2 diabetic patients compared with non-diabetic patients matched by body mass index. J Matern Fetal Neonatal Med. 2012;25:611-5.
5. Knight KM, Thornburg LL, Pressman EK. Pregnancy outcomes in type 2 diabetic patients compared with type 1 diabetic patients and nondiabetic controls. J Reprod Med. 2012;57:397-404.
6. Hawthorne G. Maternal complications in diabetic pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:77-90.
7. McCance DR. Pregnancy and diabetes. Best Pract Res Clin Endocrinol Metab. 2011;25:945-58. This review highlighted the clinical relevance of diabetes in pregnancy, evaluating pregnancy outcomes in women with type 1 and 2 diabetes.
8. Balsells M, Garcia-Patterson A, Gich I, et al. Maternal and fetal outcome in women with type 2 vs type 1 diabetes mellitus: a systematic review and meta-analysis. J Clin Endocrinol Metabol. 2009;94:4284-91.
9. Dunne F. Type 2 diabetes and pregnancy. Semin Fetal Neonat Med. 2005;10:333e339.
10. Confidential enquiry into maternal and child health. Pregnancy in women with type 1 and type 2 diabetes in 2002-2003. CEMACH study. 2005.
11. Jensen DM, Damm P, Moelsted-Pedersen L, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819-23.
12. Young BC, Ecker JL. Fetal macrosomia and shoulder dystocia in women with gestational diabetes: risks amenable to treatment? Curr Diabet Rep. 2013;13:12-8. This review considered the impact of glycemic control on neonatal morbidities resulting from the recently published randomized controlled clinical trials and from the HAPO study.
13. Langer O, Yogev Y, Most O, et al. Gestational diabetes: the consequences of not treating. Am J Obstet Gynecol. 2005;192:989-97.
14. Wendland EM, Torloni MR, Falavigna M, et al. Gestational diabetes and pregnancy outcomes- a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth. 2012;12:23.
15. Hartling L, Dryden DM, Guthrie A, et al. Screening and diagnosing gestational diabetes mellitus. Evid Rep Technol Assess. 2012;210:1-327.
16. Vandorsten JP, Dodson WC, Espeland MA, et al. NIH consensus development conference: diagnosing gestational diabetes mellitus. NIH Consens State Sci Statements. 2013;29:1-31.
17. Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy. Geneva: World Health Organization; 2013.
18. Metzger BE, Lowe LP, Dyer AR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991-2002.
19. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics. Diabetes. 2009;58:453-9.
20. American College of Obstetricians and Gynecologists. Clinical management guidelines for obstetrician-gynecologists. Fetal macrosomia. ACOG practice bulletin no.22. Washington, DC: American College of Obstetricians and Gynecologists; 2000.
21. Xu H, Simonet F, Luo ZC. Optimal birth weight percentile cut-offs in defining small- or large-for-gestational-age. Acta Paediatr. 2010;99:550.
22. Boulet SL, Alexander GR, Salihu HM, et al. Macrosomic births in the United States: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol. 2003;188:1372-8.
23. Alexander GR, Himes JH, Kaufman RB, et al. A United States national reference for fetal growth. Obstet Gynecol. 1996;87:163-8.
24. Campbell S. Fetal macrosomia: a problem in need of a policy. Ultrasound Obstet Gynecol. 2014;43:3-10. This editorial focused on the clinical significance of fetal macrosomia, providing information on the diagnosis and management.
25. Ben-Haroush A, Chen R, Hadar E, et al. Accuracy of a single fetal weight estimation at 29-34 weeks in diabetic pregnancies: can it predict large-for-gestational-age infants at term? Am J Obstet Gynecol. 2007;197:497.e1-6.
26. Suneet P, Chauhan SP, Grobman WA, et al. Suspicion and treatment of the macrosomic fetus: a review. Am J Obstet Gynecol. 2005;193:332-46.
27. Coomarasamy A, Connock M, Thornton J, et al. Accuracy of ultrasound biometry in the prediction of macrosomia: a systematic quantitative review. BJOG. 2005;112:1461-6.
28. Weissmann-Brenner A, Simchen MJ, Zilberberg E, et al. Maternal and neonatal outcomes of macrosomic pregnancies. Med Sci Monit. 2012;18:PH77-81.
29. Acker DB, Sachs BP, Friedman EA. Risk factors for shoulder dystocia in the average-weight infant. Obstet Gynecol. 1986;67:614-8.
30. Ecker JL, Greenberg JA, Norwitz ER, et al. Birth weight as a predictor of brachial plexus injury. Obstet Gynecol. 1997;89:643-7.
31. Nesbitt TS, Gilbert WM, Herrchen B. Shoulder dystocia and associated risk factors with macrosomic infants born in California. Am J Obstet Gynecol. 1998;179:476-80.
32. Overland EA, Vatten LJ, Eskild A. Pregnancy week at delivery and the risk of shoulder dystocia: a population study of 2 014 956 deliveries. BJOG. 2014;121:34-42. This large retrospective cohort study provided relevant information about the risk of shoulder dystocia according with infant birth weight classes.
33. Durnwald C, Huston-Presley L, Amini S, et al. Evaluation of body composition of large-for-gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levels. Am J Obstet Gynecol. 2004;191:804-8.
34. Catalano PM, Thomas A, Huston-Presley L, et al. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol. 2003;189:1698-704.
35. Pearson DW, Kernaghan D, Lee R, et al. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus. BJOG. 2007;114:104-7.
36. Fretts RC, Boyd ME, Usher RH, et al. The changing pattern of fetal death, 1961-1988. Obstet Gynecol. 1992;79:35-9.
37. Lauenborg J, Mathiesen E, Ovesen P, et al. Audit on stillbirths in women with pregestational type 1 diabetes. Diabetes Care. 2003;26:1385-9.
38. Tennant PW, Glinianaia SV, Bilous RW, et al. Pre-existing diabetes, maternal glycated haemoglobin, and the risks of fetal and infant death: a population-based study. Diabetologia. 2014;57:285-94. This large retrospective cohort study found that pre-existing diabetes is associated with a significant increased risk of fetal death, the effect of which is largely influenced by glycemic control.
39. Seeds JW, Peng TCC. Does augmented growth impose an increased risk of fetal death? Am J Obstet Gynecol. 2000;183:316-23.
40. Colstrup M, Mathiesen ER, Damm P, et al. Pregnancy in women with type 1 diabetes: have the goals of St. Vincent declaration been met concerning fetal and neonatal complications? Matern Fetal Neonatal Med. 2013;26:1682-6.
41. Graves CR. Antepartum fetal surveillance and timing of delivery in the pregnancy complicated by diabetes mellitus. Clin Obst Gynecol. 2007;50:1007-13.
42. Pedersen LM, Perdersen J. Causes of perinatal death in diabetic pregnancy: a clinico-pathological analysis. Acta Med Scand Suppl. 1967;476:175 - 181.
43. Evers IM, Nikkelsb PGJ, Sikkemaa J, et al. Placental pathology in women with type 1 diabetes and in a control group with normal and large-for- gestational-age infants. Placenta. 2003;24:819-25.
44. Daskalakis G, Marinopoulos S, Krielesi V, et al. Placental pathology in women with gestational diabetes. Acta Obst Gynecol Scand. 2008;87:403-7.
45. Dudley DJ. Diabetic-associated stillbirth: incidence, pathophysiology, and prevention. Obstet Gynecol Clin North Am. 2007;34:293-307.
46. Silver RM, Varner MW, Reddy U, et al. Work-up of stillbirth: a review of the evidence. Am J Obstet Gynecol. 2007;196:433-44.
47. Horvath K, Koch K, Jeitler K, et al. Effects of treatment in women with gestational diabetes mellitus: systematic review and meta-analysis. BMJ. 2010;340:c1395.
48. Landon MB, Spong CY, Thom E, et al. A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med. 2009;361:1339-48.
49. Crowther CA, Hiller JE, Moss JR, et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N Engl J Med. 2005;352:2477-86.
50. O'Sullivan JB, Gellis SS, Dandrow RV, et al. The potential diabetic and her treatment in pregnancy. Obstet Gynecol. 1966;27:683-9.
51. Rosenstein MG, Cheng YW, Snowden YM, et al. The risk of stillbirth and infant death stratified by gestational age in women with gestational diabetes. Am J Obstet Gynecol. 2012;206:309e.1 - 7. This large retrospective cohort study provided information about the risk of fetal death in GDM pregnancies according with gestational age at term.
52. Ali S, Dornhorst A. Diabetes in pregnancy: health risks and management. Postgrad Med J. 2011;87:417-27.
53. Kjos SL, Henry OA, Montoro M, Buchanan TA, et al. Insulin-requiring diabetes in pregnancy: a randomized trial of active induction of labor and expectant management. Am J Obstet Gynecol. 1993;169:611-5.
54. Boulvain M, Stan CM, Irion O. Elective delivery in diabetic pregnant women. Cochrane Database Syst Rev. 2001;2, CD001997.
55. Nicholson WK, Wilson LM, Witkop CT, et al. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evid Rep Technol Assess. 2008;162:1-96.
56. Witkop CT, Neale D, Wilson LM, et al. Active compared with expectant delivery management in women with gestational diabetes: a systematic review. Obstet Gynecol. 2009;113:206-17.
57. Rayburn WF, Sokkary N, Clokey DE, et al. Consequences of routine delivery at 38 weeks for A-2 gestational diabetes. J Matern Fetal Neonatal Med. 2005;18:333-7.
58. Lurie S, Matzkel A, Weissman A, Gotlibe Z, Friedman A. Outcome of pregnancy in class A1 and A2 gestational diabetic patients delivered beyond 40 weeks' gestation. Am J Perinatol. 1992;9:484-8.
59. Lurie S, Insler V, Hagay ZJ. Induction of labor at 38 to 39 weeks of gestation reduces the incidence of shoulder dystocia in gestational diabetic patients class A2. Am J Perinatol. 1996;13:293-6.
60. Conway DL, Langer O. Elective delivery of infants with macrosomia in diabetic women: reduced shoulder dystocia vs increased cesarean deliveries. Am J Obstet Gynecol. 1998;178:922-5.
61. Peled Y, Perri T, Chen R, et al. Gestational diabetes mellitus-implications of different treatment protocols. J Pediatr Endocrinol Metab. 2004;17:847-52.
62. Yogev Y, Ben-Haroush A, Chena R, et al. Active induction management of labor for diabetic pregnancies at term: mode of delivery and fetal outcome - a single center experience. Eur J Obstet Gynecol Reprod Biol. 2004;114:166-70.
63. Stock SJ, Duffy A, Ford I. Outcomes of elective induction of labor compared with expectant management: population based study. BMJ. 2012;344:e2838. The results of this large retrospective large cohort study on singleton pregnancies indicated that elective induction of labor at term can reduce perinatal mortality without increasing the risk of operative delivery.
64. Cheng Y, Sparks T, Laros Jr R, Nicholson J, et al. Impending macrosomia: will induction of labor modify the risk of caesarean delivery? BJOG. 2012;119:402-9. This large retrospective cohort study found that induction of labor at term may reduce the risk of caesarean delivery. This finding was clinically relevant for those cases who were induced at 39 weeks and who delivered a neonate with a birthweight of 4000 ± 125 g.
65. Wood S, Cooper S, Ross S. Does induction of labor increase the risk of caesarean section? A systematic review and meta-analysis of trials in women with intact membranes. BJOG. 2013. doi: 10.1111/1471-0528.12328. This meta-analysis provided the evidence that induction of labor in women might reduce the risk of cesarean section in both post-term pregnancies and labors induced for other high risk conditions.
66. Sanchez-Ramos L, Bernstein S, Kaunitz AM. Expectant management vs labor induction for suspected fetal macrosomia: a systematic review. Obstet Gynecol. 2002;100:997-1002.
67. Coustan DR. Gestational diabetes mellitus. Clin Chem. 2013;59:1310-21. This review focused on screening, diagnosis and management of GDM, providing clinically relevant information based on the expert view.
68. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 60. Pregestational diabetes mellitus. ACOG Committee on Practice Bulletins. Obstet Gynecol. 2005;105:675-85.
69. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 137. Gestational diabetes mellitus. ACOG Committee on Practice Bulletins. Obstet Gynecol. 2013;122(Part 1):406-16. This is the most recent guideline on management of GDM.
70. ACOG Practice Bulletin. Clinical Management Guidelines for Obstetrician-Gynecologists. Number 30. Gestational diabetes mellitus. ACOG Committee on Practice Bulletins. Obstet Gynecol. 2001;98:525-38.
71. National Institute for Health and Clinical Excellence. NICE Clinical Guideline 63: diabetes in pregnancy. Management of diabetes and its complications from pre-conception to the postnatal period. London: NICE; 2008.
72. Royal College of Obstetricians and Gynecologists. Shoulder Dystocia. Green-Top Guideline No. 42. London: RCOG Press; 2012.
73. Hoffman L, Nolan C, Wilson JD, et al. Gestational diabetes mellitus-management guidelines. The Australasian diabetes in pregnancy society. Med J Aust. 1998;69:93-7.
74. Metzger BE, Buchanan TA, Coustan DR, et al. Summary and recommendations of the Fifth International Workshop-Conference on Gestational Diabetes Mellitus. Diabetes Care. 2007;30(Suppl2):s251-60.
75. Greuter MJ, van Emmerik NM, Wouters MA, et al. Quality of guidelines on the management of diabetes in pregnancy: a systematic review. BMC Pregnancy Childbirth. 2012;12:58.
76. Elkins D, Taylor JS. Evidence-based strategies for managing gestational diabetes in women with obesity. Nurs Womens Health. 2013;17:420-9.
77. Alberico S, Montico M, Barresi V, et al. The role of gestational diabetes, pre-pregnancy body mass index and gestational weight gain on the risk of newborn macrosomia: results from a prospective multicenter study. BMC Pregnancy Childbirth. 2014;14:23. This prospective study on roughly 15,000 deliveries found that maternal obesity, gestational weight gain excess, and diabetes should be considered as independent risk factors for newborn macrosomia.
78. Persson M, Pasupathy D, Hanson U, et al. Pre-pregnancy body mass index and risk of adverse outcome in type 1 diabetic pregnancies: a population-based cohort study. BMJ Open. 2012;2:e000601. Results of this prospective population-based cohort study indicated that BMI is an important risk factor for adverse outcome in type 1 diabetic pregnancies. The combined effect of both T1DM and overweight or obesity constitutes the greatest risk.
79. Simmons D. Diabetes and obesity. Best Pract Res Clin Obstet Gynaecol. 2011;25:25-36. This review provided information about obesity and diabetes in pregnancy that have independent and additive effects on obstetric complications, both requiring specific management during pregnancy.
80. Tennant PWG, Rankin J, Bell R. Maternal body mass index and the risk of fetal and infant death: a cohort study from the North of England. Hum Reprod. 2011;26:1501-11. This large cohort study found that early pregnancy obesity is significantly associated with perinatal mortality, independent of the known relationships with congenital anomalies and maternal pregestational diabetes.
81. Sheiner E, Levy A, Menes TS, Silverberg D, et al. Maternal obesity as an independent risk factor for caesarean delivery. Paediatr Perinat Epidemiol. 2004;18:196-201.
82. Vahration A, Zhang J, Troendle JF, et al. Maternal pre-pregnancy overweight and obesity and the pattern of labor progression in term nulliparous women. Obstet Gynecol. 2004;104:943-51.
83. Hirshberg A, Levine LD, Srinivas S. Labor length among overweight and obese women undergoing induction of labor. J Matern Fetal Neonatal Med. 2014. [In press]. This retrospective cohort study on term inductions found an association between BMI and labor length. BMI also influences the stage of labor in which a cesarean occurs.
84. Wolfe KB, Rossi RA, Warshak CR. The effect of maternal obesity on the rate of failed induction of labor. Am J Obstet Gynecol. 2011;205:128.e1-7.
85. Gunatilake RP, Smrtka MP, Harris B, et al. Predictors of failed trial of labor among women with an extremely obese body mass index. Am J Obstet Gynecol. 2013;209(562):e1-5.
86. Yogev Y, Ben-Haroush A, Chen R, et al. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol. 2004;191:949-53.
87. Langer O. A spectrum of glucose thresholds may effectively prevent complications in the pregnant diabetic patient. Semin Perinatol. 2002;26:196-205.
88. de Veciana M, Major CA, Morgan MA, et al. Postprandial vs preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N Eng J Med. 1995;333:1237-41.
89. González-Quintero VH, Istwan NB, Rhea DJ, et al. The impact of glycemic control on neonatal outcome in singleton pregnancies complicated by gestational diabetes. Diabetes Care. 2007;30:467-70.
90. Thompson D, Capes S, Feig DS, et al. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Diabetes and Pregnancy. In Canadian Diabetes Association 2008. Clinical practice guideline for the prevention and management of diabetes in Canada. Can J Diabetes 2008, 32(Suppl.1): S168 - S180.
91. Jovanovič L. The importance of preconception care in women with pre-existing diabetes. Curr Diab Pract. 2006;6:1-4.
92. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915-8.
93. Blackwell SC, Hassan SS, Wolfe HW, et al. Why are cesarean delivery rates so high in diabetic pregnancies? J Perinat Med. 2000;28:316-20.
94. Moses RG, Knights SJ, Lucas EM, et al. Gestational diabetes: is a higher cesarean section rate inevitable? Diabetes Care. 2000;23:15-7.
95. Takoudes TC, Weitzen S, Slocum J, et al. Risk of cesarean wound complications in diabetic gestations. Am J Obstet Gynecol. 2004;191:958-63.
96. Myles TD, Gooch J, Santolaya J. Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery. Obstet Gynecol. 2002;100:959-64.
97. Davies GA, Maxwell C, McLeod L, et al. SOGC clinical practice guidelines: obesity in pregnancy. No. 239. Int J Gynaecol Obstet. 2010;110:167-73.
98. Laughon SK, Zhang J, Troendle J, Sun L, Reddy UM. Using a simplified Bishop score to predict vaginal delivery. Obstet Gynecol. 2011;117:805-11.
99. Maso G, Alberico S, Wiesenfeld U, et al. GINEXMAL RCT: induction of labor vs expectant management in gestational diabetes pregnancies. BMC Pregnancy Childbirth. 2011;11:31. The present trial will provide evidence as to whether or not, in women affected by gestational diabetes, induction of labor at 38-39 weeks is an effective management to ameliorate maternal and neonatal outcomes.
100. Chauhan SP, Ananth CV. Induction of labor in the United States: a critical appraisal of appropriateness and reducibility. Semin Perinatol. 2012;36:336-43.
101. Fitzpatrick KE, Sellers S, Spark P, et al. Incidence and risk factors for placenta accreta/increta/percreta in the UK: a national case-control study. PLoS One. 2012;7:e52893.
102. Silver RM. Implications of the first cesarean: perinatal and future reproductive health and subsequent cesareans, placentation issues, uterine rupture risk, morbidity, and mortality. Semin Perinatol. 2012;36:315-23.